Molecular Biomarkers to Assess Kidney Allograft Status
- 6 October 2025
- book chapter
- Published by Springer Nature
- p. 115-127
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Does the Transplant System Fail Patients Following Kidney Allograft Loss?American Journal of Kidney Diseases, 2025
- Cell-free DNA for the detection of kidney allograft rejectionNature Medicine, 2024
- Challenges in the management of the kidney allograft: from decline to failure: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies ConferenceKidney International, 2023
- Thirty years of the International Banff Classification for Allograft Pathology: the past, present, and future of kidney transplant diagnosticsKidney International, 2022
- Principles of Virtual Crossmatch Testing for Kidney TransplantationKidney International Reports, 2022
- Long-Term Survival after Kidney TransplantationNew England Journal of Medicine, 2021
- The challenge of using the virtual crossmatch as a singular tool for the detection of Anti-HLA antibodies- A study from a tertiary care institute from South IndiaTransplant Immunology, 2021
- Cell-Free DNA and Apoptosis: How Dead Cells Inform About the LivingTrends in Molecular Medicine, 2020
- Immune cell function testing: an adjunct to therapeutic drug monitoring in transplant patient managementClinical Transplantation, 2003
- Presence of donor-specific DNA in plasma of kidney and liver-transplant recipientsThe Lancet, 1998